A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|February 20, 2006
New product newswire: February 20, 2006
For Cipher Pharmaceuticals, Mississauga, Ont., (905) 602-5840,Lipofen (fenofibrate capsules) has been approved in strengths of50, 100, and 150 mg.
Advertisement
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary Goals
3
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
4
COVID-19 Vaccines Paid Off Up to $809 Per Dollar Spent in 2021
5